Pliant Therapeutics, Inc. (PLRX)
1.35
+0.03
(+2.27%)
USD |
NASDAQ |
Apr 02, 16:00
1.35
0.00 (0.00%)
After-Hours: 20:00
Pliant Therapeutics EPS Diluted (Quarterly) : -0.3837 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 0.5326 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.58M |
| Total Expenses (Quarterly) | 23.58M |
| Enterprise Value | -78.25M |
| Earnings Yield | -176.3% |
| Normalized Earnings Yield | -172.69 |